Share this post on:

Product Name :
Inetetamab

Search keywords :
Inetetamab

drugId :
null

Target Vo:
Receptor protein-tyrosine kinase erbB-2

Target Vo Short Name :
HER2

Moa_Name:
Antibody-dependent cell-mediated cytotoxicity (ADCC) effects

First Approval Country :
Mainland China

First Approval Date Filter:
2020

Origin Company_Name :
Sunshine GuoJian Pharmaceutical (Shanghai) Co Ltd

Active Company_Name :
Chengdu Scimount Pharmatech Co Ltd

Active Indication_Name:
Breast Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Sutimlimab web
Aldafermin Autophagy
SRT Tag Antibody (YA884): SRT Tag Antibody (YA884) is an unconjugated, mouse-derived, anti-SRT Tag (YA884) monoclonal antibody. SRT Tag Antibody (YA884) can be used for: WB expriments in species-independent background without labeling.

Share this post on:

Author: Betaine hydrochloride